-

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

  • Sourced from the diabetes community at large through an open call earlier this year, the 16 selected advocates represent strength, advocacy and pride in living with Type 1, Type 2 and prediabetes
  • Dexcom’s World Diabetes Day campaign provides a platform for the selected individuals to advocate for diabetes awareness through their unique, personal stories on a global stage

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom’s World Diabetes Day campaign.

The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person’s experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom’s glucose biosensing technology.

“Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals,” said Maria Alejandra Jove Valerio, one of Dexcom’s new advocates. “What began as a diagnosis at age seven has grown into a lifelong mission to uplift others.”

This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom’s history of and commitment to giving real people with diabetes a platform to share their story on a global stage.

Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate’s personal experience with diabetes, what misconceptions about diabetes they’d like to dispel and how they want to inspire others with diabetes to discover what they’re made of.

To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo* Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day.

Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes.

“Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique and compelling story, but they are all bonded by the shared experience of living with diabetes and passion for helping others in their diabetes journey,” said Lundberg. “I’m looking forward to people around the world seeing the strength of their advocacy shine through in this meaningful campaign.”

Meet the New Dexcom Diabetes Advocates:

  • Ben Schwinof: Portland, OR, United States | Age 50, Type 2 Diabetes
  • Bridget Curran: New York, NY, United States | Age 56, Prediabetes
  • Bruce Moss: Durango, CO, United States | Age 67, Type 1 Diabetes
  • Cindy Reinl: Stuttgart, Germany | Age 26, Type 1 Diabetes
  • Darrell Byers: Boston, United States | Age 64, Type 2 Diabetes
  • Isabelle da Silva: Boca Raton, FL, United States | Age 6, Type 1 Diabetes
  • Jacob Cain: Mesa, AZ, United States | Age 49, Type 2 Diabetes
  • Kari Cichoski: Las Vegas, NV, United States | Age 38, Type 1 Diabetes
  • Kate Beaulieu: Toronto, ON, Canada | Age 20, Type 1 Diabetes
  • Kaye Peterson: Lebanon, KY, United States | Age 68, Type 1 Diabetes
  • Lachie Kennedy: Brisbane, Australia | Age 22, Type 1 Diabetes
  • Maria Alejandra Jove Valerio: Boston, MA, United States | Age 20, Type 1 Diabetes
  • MiYeong Kim: Seoul, South Korea | Age 48, Mother to a Son with Type 1 Diabetes
  • Sofia Pansini: Boston, MA, United States | Age 21, Type 1 Diabetes
  • Tajah Russell: Dallas, TX, United States | Age 31, Type 1 Diabetes
  • Tai'yon Allen Walker: Annapolis, MD, United States | Age 11, Type 1 Diabetes

To learn more about the advocates’ stories, visit Dexcom.com/WorldDiabetesDay or follow Dexcom on Facebook, Instagram or TikTok.

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

*Stelo is cleared by the FDA for adults not on insulin who are 18 older in the United States.

Contacts

Media Contact
Nadia Conard
mediarelations@dexcom.com

Investor Contact
Sean Christensen
sean.christensen@dexcom.com

DexCom, Inc.

NASDAQ:DXCM

Release Versions

Contacts

Media Contact
Nadia Conard
mediarelations@dexcom.com

Investor Contact
Sean Christensen
sean.christensen@dexcom.com

More News From DexCom, Inc.

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real‑time glucose readings for an industry‑leading 15.5 days5. Building on the performance of Dexcom CGM whi...

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the company's second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will...

Dexcom Further Advances Vision of Glucose Biosensing for All

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible. Notably, the company announced pediatric clearance for the Stelo Glucose Biosensor and the launch of its fully reimagined Stelo app experience in July for Apple iPhone and Android users in the United States.“Glucose matters for everyone and better understanding it can h...
Back to Newsroom